• Video file
    Some see slow and steady scientific progress.

    We see a revolution.

    Sarepta is a global biotechnology company on an urgent mission: engineer precision genetic medicine to reclaim futures otherwise impacted or cut short by rare diseases.

    We’re ushering in a new era of drug development, with the goal of shortening the time from lab to patient, building the world’s largest gene therapy manufacturing capacity, and rethinking access and reimbursement models for revolutionary new treatments. We are in a daily race to transform genetic understanding into genetic medicine. Because every day is an opportunity to change the lives of people living with rare disease.

  • Video file
    Some think a cure for a rare disease is a miracle.

    Our scientists would disagree.

    Sarepta is engineering solutions for rare diseases with science that is on the forefront of precision genetic medicine. Our platforms include: gene therapy, RNA technologies, and gene editing. We are in a daily race to save lives stolen or impacted by rare disease.

  • Video file
    Patients can’t wait for the next breakthrough in medical research.

    So neither will we.

    While there may be as many as 7,000 rare diseases, only a small percentage have treatments. That is why we are relentless in our dedication: Leverage the best science to help as many patients as possible. Today, we are doing just that in Duchenne muscular dystrophy, in six forms of limb-girdle muscular dystrophy, in Charcot-Marie-Tooth disease, and in Mucopolysaccharidosis type IIIA (MPS IIIA), among others. Sarepta will always follow the science and continuously evaluate other diseases and modalities to pursue.

  • Sarepta Columbus
    The opportunity to transform lives is breathtaking.

    Join us.

    We see endless possibilities for changing the future of medicine. We’re looking for people who see unlimited potential in themselves, opportunity where others see roadblocks, and solutions limited only by the power of imagination and the drive to do things differently.

Coronavirus graphic

Sarepta’s Response to COVID-19

For patients in the U.S. taking an approved Sarepta therapy, please contact SareptAssist at +1-888-727-3782 with any questions.

For participants in Sarepta-sponsored clinical trials, Sarepta is working closely with your site teams to mitigate disruptions caused by COVID-19 and we encourage you to contact your site team to understand the status of your upcoming visits. The Sarepta team is committed to helping you navigate disruptions in your trial participation and can be reached at +1-800-690-2003 or via email [email protected] to answer any questions or concerns during this uncertain time.

Mar. 19, 2020: Sarepta Response to COVID-19 [Read our Statement]